What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Searched for "active".
Recall
|
Medicines
|
19/12/2013
In a letter dated December 19, 2013, the marketing authorization holder informed its customers that an elevated level of a known degradation product of the active ingredient azithromycin has been detected in some vials and that a voluntary recall is…
Recall
|
Medicines
|
11/07/2013
The marketing authorization holder informed its supplied customers in a letter dated July 9, 2013, that in the course of quality assurance measures it was determined that in batch 1200758 isolated ampoules with yellowish discolored contents and thus…
Safety warnings
|
messages in brief
|
28/06/2013
Ergot derivatives (various preparations)
messages in brief
|
27/06/2013
More than 100 countries participated in this year's week of action against the illegal sale of medicines on the Internet. In total, more than nine million potentially dangerous medicines worth around 41 million US dollars were seized worldwide.…
messages in brief
|
26/06/2013
As of 02.07.2013, new regulations apply to the import of active ingredients for medicinal products for human use into the European Union. As of this date, active substances for medicinal products for human use may only be imported if at least one of…
Recall
|
Medicines
|
04/06/2013
The marketing authorization holder informed its supplied customers in a letter dated June 3, 2013, that in the course of stability tests after 24 months of storage, non-specification-compliant results were found for a batch of Cileste in the…
Safety warnings
|
messages in brief
|
18/04/2013
Methotrexate (various preparations)
messages in brief
|
14/02/2013
If there are major differences in the measurement of pharmacokinetic parameters, such as the AUC or Cmax, after repeated administration of the identical drug, it is reasonable to suspect that the specific product or the active ingredient itself could…
Safety warnings
|
messages in brief
|
29/01/2013
Combined oral contraceptives (COCs) are divided into four generations depending on the type of progestogen they contain. The European Medicines Agency (EMA) is evaluating the need for a change in the indication of third- and fourth-generation…
messages in brief
|
16/11/2012
In order to achieve the highest possible level of health protection, very high quality requirements are placed on the manufacture of medicinal products. As a result, only drugs whose quality, efficacy and safety are guaranteed are released for…